(Q40471536)

20 September 2017

Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. (English)

1 reference

20 September 2017

0 references

Claire Gondeau

1

1 reference

20 September 2017

Sabine Gerbal-Chaloin

2

1 reference

20 September 2017

Paul Bello

3

1 reference

20 September 2017

Gudrun Aldrian-Herrada

4

1 reference

20 September 2017

May C Morris

5

1 reference

20 September 2017

Gilles Divita

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

13 January 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

13793-13800

1 reference

20 September 2017

14

1 reference

Cyclin-dependent kinases: engines, clocks, and microprocessors

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Modulating cell cycle: current applications and prospects for future drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Issues and progress with protein kinase inhibitors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Protein kinase inhibitors: insights into drug design from structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Cell-cycle targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Small molecules as inhibitors of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

The specificities of protein kinase inhibitors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Interactions of cyclins with cyclin-dependent kinases: a common interactive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Crystal structure of cyclin-dependent kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Structural basis of cyclin-dependent kinase activation by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Regulation of protein kinases; controlling activity through activation segment conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

An artificial cell-cycle inhibitor isolated from a combinatorial library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

The crystal structure of cyclin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413690200

21 January 2018

Identifiers

DOI

10.1074/JBC.M413690200

1 reference

20 September 2017

1 reference